SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genta, Inc. (GNTA)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1870 44 0 GNTA
Emcee:  John Nobrega Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1695MORE FUNDING NEWS: Genta gets $40,000,000. extended line of credit from AventisJohn William Anderson-3/17/2003
1694Regarding ISIS / LLY litmus test failure: Genta is going after a completelyJohn William Anderson-3/17/2003
1693"Isis lung cancer data a litmus test for Antisense" cbs.marketwatch.coJohn William Anderson-3/4/2003
1692aventis must be pretty sure of gentasense to back the drug... is genta down justsammaster-2/28/2003
1691Genta On Track To Launch Ganite In Second Half By HOLLISTER H. HOVEY Of DOW JONEJim Oravetz-2/27/2003
1690Genta Incorporated to Present at Raymond James Annual Institutional Investors Cobob zagorin-2/25/2003
1689Genta Incorporated to Present in Roundtable and Corporate Sessions At Bio Ceo &abob zagorin-2/21/2003
1688U.S. BANCORP PIPER JAFFRAY issued the following share price target changes on Thbob zagorin-2/14/2003
1687Genta Reports Fourth Quarter and Year End 2002 Results and Progress BERKELEY bob zagorin-2/13/2003
1686Genta to Address Year End Financial 2002 Results and Progress In Conference Callbob zagorin-2/6/2003
1685new coverage today Coverage Initiated Company Symbol Brokerage Firm Initial Ratbob zagorin-2/5/2003
1684Genta Incorporated to Present at U.S. Bancorp Piper Jaffray Health Care Conferenbob zagorin-1/23/2003
1683BCNJ Appoints New Officers and President to Board of Trustees TRENTON, N.J., bob zagorin-1/13/2003
1682Coverage Reiterated * Company Symbol Brokerage Firm Reiterated Rating: Target bob zagorin-1/8/2003
1681Genta Provides Clinical and Regulatory Update on Its Lead Anticancer Compound, Gbob zagorin-1/7/2003
1680Genta Announces Reactivation of New Drug Application (NDA) For Ganite(TM) and Inbob zagorin-1/3/2003
1679Briefing: 14:59 ET KERX Unusual Volume -- Keryx Biopharma (1.45 +0.15) Mictom pope-12/23/2002
1678he was an officer but has not been listed as an officer for some time. not usre bob zagorin-12/23/2002
1677re: Weiss appointment. How is this significant to Genta?613-12/23/2002
1676Keryx Announces Senior Management Changes Michael S. Weiss Appointed Chairman anbob zagorin-12/23/2002
1675Genta Incorporated (GNTA) And Avecia Sign Long-Term Manufacturing And Supply Agrbob zagorin-12/23/2002
1674genta gets a line at end of ths story. Pfizer, San Diego Biotechnology Firm Joibob zagorin-12/20/2002
1673Early Clinical Results Suggest Genasense(TM) May Be Useful for Patients With Higbob zagorin-12/10/2002
1672Here's the scoop on institutional ownership: biz.yahoo.comJohn William Anderson-12/10/2002
1671Single-Agent Activity of Genta's Lead Anticancer Compound, Genasense(TM), bob zagorin-12/9/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News